Kim Hung Lo
- Physiology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Rheumatology top 1%
- Immunology top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Co-authors
- Eugene S. ChungMilton PackerJames T. WillersonAdedigbo A. FasanmadeMarc A. JudsonElliot S. BarnathanRobert P. BaughmanSusan Flavin
- Topics
- Rheumatoid Arthritis Research and Therapies (17 papers)Autoimmune and Inflammatory Disorders Research (16 papers)Spondyloarthritis Studies and Treatments (14 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Kim Hung Lo
52 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Physiology 1.3k
- Pulmonary and Respiratory Medicine 1.1k
- Rheumatology 813
- Immunology 708
- Cardiology and Cardiovascular Medicine 649
Countries citing papers authored by Kim Hung Lo
This map shows the geographic impact of Kim Hung Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Hung Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Hung Lo more than expected).
Fields of papers citing papers by Kim Hung Lo
This network shows the impact of papers produced by Kim Hung Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Hung Lo. The network helps show where Kim Hung Lo may publish in the future.
Co-authorship network of co-authors of Kim Hung Lo
This figure shows the co-authorship network connecting the top 25 collaborators of Kim Hung Lo. A scholar is included among the top collaborators of Kim Hung Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Hung Lo. Kim Hung Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 11 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 9 | |
| 8 | 6 | |
| 9 | 4 | |
| 10 | 6 | |
| 11 | 16 | |
| 12 | 43 | |
| 13 | Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. | 33 |
| 14 | 15 | |
| 15 | 23 | |
| 16 | 370 | |
| 17 | 78 | |
| 18 | 473 | |
| 19 | 3 | |
| 20 | 1 |
About Kim Hung Lo
Kim Hung Lo is a scholar working on Rheumatology, Hematology and Physiology, having authored 54 papers that have together received 3.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (17 papers), Autoimmune and Inflammatory Disorders Research (16 papers) and Spondyloarthritis Studies and Treatments (14 papers). The work is most often cited by research in Rheumatology (813 citations), Physiology (1.3k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Kim Hung Lo has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Eugene S. Chung, Milton Packer, James T. Willerson, Adedigbo A. Fasanmade, Marc A. Judson, Elliot S. Barnathan, Robert P. Baughman, Susan Flavin, Marjolein Drent and Ulrich Costabel. Their work appears in journals such as The Lancet, Circulation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.